(S1 (S (NP (NN NF-kappaB) (NN activation)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NP (NP (NN IL-1beta)) (CC and) (NP (NN IL-8))) (NNS responses)) (PP (TO to) (NP (FW P.) (FW aeruginosa)))))))))
(S1 (S (S (NP (PRP We)) (VP (VBD confirmed) (NP (NP (DT the) (NN dependence)) (PP (IN of) (NP (NP (JJ PAO1-induced) (NN IL-1beta)) (CC and) (NP (NN IL-8) (NN production)))) (PP (IN on) (NP (NN NF-kappaB) (NN activation)))) (S (VP (VBG using) (NP (NP (NN THP-1) (NNS cells)) (VP (VBG expressing) (NP (NP (DT a) (NN reporter)) (VP (VBN driven) (PP (IN by) (NP (NP (NN NF-kappaB)) (CC and) (NP (NN AP-1)) (NP (NN response) (NNS elements)))))))))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (S (NP (NP (NN stimulation)) (PP (IN of) (NP (VBN primed) (NN THP-1) (NN reporter) (NNS cells))) (PP (IN with) (NP (JJ heat-killed) (NNS PAO1)))) (VP (VBD produced) (NP (NP (NP (DT the) (JJS highest) (NNS levels)) (PP (IN of) (NP (NN NF-kappaB/AP-1) (NN activation))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6a)) (-RRB- -RRB-))) (CC and) (NP (NP (DT this)) (VP (VBN correlated) (PP (IN with) (NP (NN IL-8) (NN secretion)))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6b)) (-RRB- -RRB-)))) (CC but) (S (NP (NP (JJ negligible) (NNS amounts)) (PP (IN of) (NP (NN IL-1beta)))) (VP (VBD were) (VP (VBN secreted) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6c)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (VBN primed) (NN THP-1) (NN reporter) (NNS cells))) (PP (IN with) (NP (JJ live) (NNS PAO1)))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB increase) (NP (NP (NP (NN NF-kappaB/AP-1) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6a)) (-RRB- -RRB-))) (CC or) (NP (NP (NN IL-8) (NN secretion)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6b)) (-RRB- -RRB-)))) (PP (IN over) (NP (NP (NN priming)) (ADVP (RB alone))))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN IL-1beta) (NN production)) (VP (VBD was) (VP (ADVP (RB greatly)) (VBN augmented) (PP (IN over) (NP (NP (VBN primed) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (JJ heat-killed) (NNS PAO1)) (CC or) (NP (JJ unprimed) (NNS cells))) (VP (VBN stimulated) (PP (IN with) (NP (NP (JJ live) (NNS PAO1)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6c)) (-RRB- -RRB-))))))))))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBD confirmed) (SBAR (IN that) (S (S (NP (NP (NN NF-kappaB) (NN activation)) (ADVP (RB alone))) (VP (VBZ is) (RB not) (ADJP (JJ sufficient) (PP (IN for) (NP (JJ maximal) (NN IL-1beta) (NN secretion)))))) (, ,) (CC but) (S (NP (NP (VBN increased) (NN priming)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG augmenting) (NP (NP (NN IL-1beta) (NN production)) (CC and) (NP (NN secretion))) (PP (IN upon) (NP (NN inflammasome) (NN stimulation))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Dependency)) (PP (IN of) (NP (DT these) (NNS responses))) (PP (IN on) (NP (NN NF-kappaB)))) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (NP (JJ pharmacologic) (NN inhibition)) (PP (IN of) (NP (NN NF-kappaB))))) (S (VP (VBG using) (NP (NP (DT the) (NN Bay11-7082) (NN inhibitor)) (PP (IN of) (NP (NP (NN IkappaBalpha) (NN phosphorylation)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (NP (NP (NN NF-kappaB/AP-1) (NN activation)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.001)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6d)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (JJ subsequent) (NN production)) (PP (IN of) (NP (NP (NP (NP (NN IL-8)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.01)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6e)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN IL-1beta)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.001)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 6f)) (-RRB- -RRB-))))))) (PP (IN in) (NN response) (TO to) (NP (ADJP (CC both) (ADJP (JJ heat-killed)) (CC and) (ADJP (JJ live))) (NN PAO1)))))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBD were) (ADVP (RB also)) (VP (VBN verified) (PP (IN in) (NP (NN CF) (CC and) (NN control) (NNS PBMCs))) (PP (IN for) (NP (NP (DT each) (NN inflammasome)) (VP (VBN examined) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.001)) (-RRB- -RRB-))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6g-h)) (-RRB- -RRB-))))) (. .)))
(S1 (S (S (ADVP (RB Overall)) (NP (DT these) (NNS results)) (VP (VBP confirm) (SBAR (SBAR (IN that) (S (NP (NN NF-kappaB)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN modulator)) (PP (IN of) (NP (NN IL-1beta) (NN production))))))) (CC and) (SBAR (IN that) (S (NP (NP (VBN increased) (NN activation)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VBZ augments) (NP (NP (JJ inflammasome-mediated) (NN production)) (PP (IN of) (NP (NN IL-1beta)))))))))) (. .)))
